IDRX, Inc., a wholly owned subsidiary of GSK, LLC
1 clinical trials · Sponsor
◉ Watch IDRX, Inc., a wholly owned subsidiary of GSK, LLC
| Record | Firm | Date |
|---|---|---|
| First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (NCT05489237) | IDRX, Inc., a wholly owned subsidiary of GSK, LLC | 2022-08-03 |
Track IDRX, Inc., a wholly owned subsidiary of GSK, LLC automatically
Every clearance here is in the API, with alerts when new ones post.